Whether the treatment efficacy could be better predictable using assessment of VLF spectral power and insulin resistance profile, and/or it could be further supported e.g. by pharmacological agents (such as metformin or insulin sensitisers33) or other means, this should be investigated in further prospective trials. Here, INS is linked to Insulin resistance.